Cargando…

Correction: The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator

Detalles Bibliográficos
Autores principales:	Sotnikova, Tatyana D., Beaulieu, Jean-Martin, Espinoza, Stefano, Masri, Bernard, Zhang, Xiaodong, Salahpour, Ali, Barak, Larry S., Caron, Marc G., Gainetdinov, Raul R.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965771/ http://dx.doi.org/10.1371/annotation/a2019934-b1cc-4781-80cb-9e09fc7ff6dc

Ejemplares similares

The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator
por: Sotnikova, Tatyana D., et al.
Publicado: (2010)

Dopamine-Independent Locomotor Actions of Amphetamines in a Novel Acute Mouse Model of Parkinson Disease
por: Sotnikova, Tatyana D, et al.
Publicado: (2005)

BRET biosensors to study GPCR biology, pharmacology, and signal transduction
por: Salahpour, Ali, et al.
Publicado: (2012)

The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
por: Managò, Francesca, et al.
Publicado: (2012)

Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor
por: Sotnikova, Tatyana D., et al.
Publicado: (2020)

Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors
por: Beaulieu, Jean-Martin, et al.
Publicado: (2011)

A high sensitivity LC-MS/MS method for measurement of 3-methoxytyramine in plasma and associations between 3-methoxytyramine, metanephrines, and dopamine
por: Smy, Laura, et al.
Publicado: (2021)

Alternative pathway for dopamine production by acetogenic gut bacteria that O‐Demethylate 3‐Methoxytyramine, a metabolite of catechol O‐Methyltransferase
por: Rich, Barry E., et al.
Publicado: (2022)

Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397
por: Espinoza, Stefano, et al.
Publicado: (2018)

Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson’s Disease Therapy
por: Sukhanov, Ilya, et al.
Publicado: (2022)

Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma
por: Rao, Dipti, et al.
Publicado: (2017)

Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma
por: Gupta, Poonam, et al.
Publicado: (2015)

Urinary 3-Methoxytyramine Is a Biomarker for MYC Activity in Patients With Neuroblastoma
por: Verly, Iedan R. N., et al.
Publicado: (2022)

Neurofibromatosis-related phaeochromocytoma: two cases with large tumours and elevated plasma methoxytyramine
por: Teasdale, Stephanie, et al.
Publicado: (2015)

Cabergoline reduces 3-methoxytyramine in a SDHC patient with metastatic paraganglioma and prolactinoma
por: Hussein, Ziad, et al.
Publicado: (2021)

Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine
por: Richter, Susan, et al.
Publicado: (2022)

Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression
por: Calipari, Erin S., et al.
Publicado: (2013)

Neuromodulation of Foraging Decisions: The Role of Dopamine
por: Marzecová, Anna, et al.
Publicado: (2021)

Correction: The Stem Cell-Expressed Receptor Lgr5 Possesses Canonical and Functionally Active Molecular Determinants Critical to β-arrestin-2 Recruitment
por: Snyder, Joshua C., et al.
Publicado: (2014)

Recombinant Adeno-Associated Virus-mediated rescue of function in a mouse model of Dopamine Transporter Deficiency Syndrome
por: Illiano, P., et al.
Publicado: (2017)

Correction to: Biomarkers and neuromodulation techniques in substance use disorders
por: Habelt, Bettina, et al.
Publicado: (2020)

Publisher Correction: A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers
por: Cataldi, Rodrigo, et al.
Publicado: (2021)

CORRIGENDUM TO: Neuromodulation for treatment-resistant depression
por: Holtzheimer, Paul E., et al.
Publicado: (2012)

Novel translational rat models of dopamine transporter deficiency
por: Leo, Damiana, et al.
Publicado: (2018)

Male/Female Differences in Neuroprotection and Neuromodulation of Brain Dopamine
por: Bourque, Mélanie, et al.
Publicado: (2011)

Correction: Roles of bile acids signaling in neuromodulation under physiological and pathological conditions
por: Xing, Chen, et al.
Publicado: (2023)

The neuromodulator of exploration: A unifying theory of the role of dopamine in personality
por: DeYoung, Colin G.
Publicado: (2013)

Correction: Rare-earth based materials: an effective toolbox for brain imaging, therapy, monitoring and neuromodulation
por: Wei, Zheng, et al.
Publicado: (2022)

Author Correction: Noninvasive sub-organ ultrasound stimulation for targeted neuromodulation
por: Cotero, Victoria, et al.
Publicado: (2020)

Behavioral Effects of a Potential Novel TAAR1 Antagonist
por: Lam, Vincent M., et al.
Publicado: (2018)

Dual-Template Magnetic Molecularly Imprinted Polymer for Simultaneous Determination of Spot Urine Metanephrines and 3-Methoxytyramine for the Diagnosis of Pheochromocytomas and Paragangliomas
por: Zeng, Hongyu, et al.
Publicado: (2022)

Altered Sexual Behavior in Dopamine Transporter (DAT) Knockout Male Rats: A Behavioral, Neurochemical and Intracerebral Microdialysis Study
por: Sanna, Fabrizio, et al.
Publicado: (2020)

Early Adolescence Prefrontal Cortex Alterations in Female Rats Lacking Dopamine Transporter
por: Illiano, Placido, et al.
Publicado: (2021)

Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control
por: Speranza, Luisa, et al.
Publicado: (2021)

Correction: Neuromodulation for recovery of trunk and sitting functions following spinal cord injury: a comprehensive review of the literature
por: Tharu, Niraj Singh, et al.
Publicado: (2023)

Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
por: Savchenko, Artem, et al.
Publicado: (2023)

Editorial: Application of Plant Secondary Metabolites to Pain Neuromodulation
por: Singla, Rajeev K., et al.
Publicado: (2021)

CNS neurotransmitters and neuromodulators : dopamine
Publicado: (1996)

Correction: Dopamine Inhibits Mitochondrial Motility in Hippocampal Neurons
por: Chen, Sigeng, et al.
Publicado: (2008)

Correction: Dopamine Inhibits Mitochondrial Motility in Hippocampal Neurons
por: Chen, Sigeng, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_npvpra8rbke4v95jj12rgt3ti3